Acute pain in children and adults with sickle cell disease: Management in the absence of evidence-based guidelines

Current Opinion in Hematology

Volumn 16, Issue 3, 2009, Pages 173-178

  Field, Joshua J ^a,b   Knight Perry, Jessica E ^a   DeBaun, Michael R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hematology   (United States)

Author keywords

Pain; Sickle cell disease; Vaso occlusion

Indexed keywords

IBUPROFEN; MORPHINE; OPIATE; PARACETAMOL;

ANAMNESIS; CHILD; CLINICAL DECISION MAKING; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; EVIDENCE BASED PRACTICE; HUMAN; PAIN; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; VASO OCCLUSIVE PAIN;

ACUTE DISEASE; ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; HUMANS; PAIN;

EID: 67749118113     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e328329e167     Document Type: Review

References (27)

1. Hassell K. Sickle cell disease population estimation: application of available contemporary data to traditional methods. In: 35th Anniversary Convention of the National Sickle Cell Disease Program; 2007; Washington, DC.
2. Hoover R, Rubin R, Wise G, Warren R. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood 1979; 54:872-876.
3. Hebbel RP, Boogaerts MA, Eaton JW, et al. Erythrocyte adherence to endothelium in sickle cell anemia: a possible determinant of disease severity. N Engl J Med 1980; 302:992-995.
4. Frenette PS. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation 2004; 11:167-177.
5. Belcher JD, Marker PH, Weber JP, et al. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vasoocclusion. Blood 2000; 96:2451-2459.
6. Antonucci R, Walker R, Herion J, Orringer E. Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 1990; 34:44-48.
7. Wun T, Paglieroni T, Tablin F, et al. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med 1997; 129:507-516.
8. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004; 11:129-151.
9. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991; 325:11-16.
10. Bookchin RM, Nagel RL, Balazs T. Role of hybrid tetramer formation in gelation of haemoglobin S. Nature 1975; 256:667-668.
11. Morris CR. Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology Am Soc Hematol Educ Program 2008; 2008: 177-185.
12. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007; 21:37-47.
13. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006; 107:2279-2285.
14. Ballas SK. Sickle cell anemia with few painful crises is characterized by decreased red cell deformability and increased number of dense cells. Am J Hematol 1991; 36:122-130.
15. Alexander N, Higgs D, Dover G, Serjeant GR. Are there clinical phenotypes of homozygous sickle cell disease? Br J Haematol 2004; 126:606-611.
16. Frei-Jones MJ, Field JJ, DeBaun MR. Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease. Pediatr Blood Cancer 2009; 52:481-485. This study finds that lack of outpatient follow-up within 30 days after hospital discharge is a risk for readmission.
17. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008; 148:94-101. This study establishes that adults with sickle cell disease frequently manage acute pain events at home without physician contact
18. Glassberg J, Spivey JF, Strunk R, et al. Painful episodes in children with sickle cell disease and asthma are temporally associated with respiratory symptoms. J Pediatr Hematol Oncol 2006; 28:481-485.
19. Nolan VG, Zhang Y, Lash T, et al. Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a case-crossover study. Br J Haematol 2008; 143:433-438.
20. Jones S, Duncan ER, Thomas N, et al. Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate. Br J Haematol 2005; 131:530-533.
21. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol 2005; 79:17-25.
22. Panepinto JA, Brousseau DC, Hillery CA, Scott JP. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer 2005; 44:182-186.
23. Quinn CT. A question of quality in sickle cell disease. Pediatr Blood Cancer 2009; 52:435-436.
24. Luffy R, Grove SK. Examining the validity, reliability, and preference of three pediatric pain measurement tools in African-American children. Pediatr Nurs 2003; 29:54-59.
25. Melzer-Lange MD, Walsh-Kelly CM, Lea G, et al. Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. Pediatr Emerg Care 2004; 20:2-4.
26. Gonzalez ER, Bahal N, Hansen LA, et al. Intermittent injection vs patientcontrolled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department. Arch Intern Med 1991; 151:1373-1378.
27. van Beers EJ, van Tuijn CF, Nieuwkerk PT, et al. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007; 82:955-960. This study demonstrates that patient-controlled analgesia reduces the consumption of morphine during an acute pain event and is equally effective at controlling pain compared to a continuous infusion.